159 related articles for article (PubMed ID: 37779926)
1. Synthesis of Novel Heterocyclic Ferrocenyl Chalcones and Their Biological Evaluation.
Alsina-Sánchez ÁM; Montalvo-Vázquez S; Grafals-Ruiz N; Acosta C; Ormé EM; Rodríguez I; Delgado-Rivera SM; Tinoco AD; Dharmawardhane S; Montes-González IC
ACS Omega; 2023 Sep; 8(38):34377-34387. PubMed ID: 37779926
[TBL] [Abstract][Full Text] [Related]
2. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
[TBL] [Abstract][Full Text] [Related]
3. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Anticancer and Antitubercular Properties of New Chalcones and Their Nitrogen-Containing Five-Membered Heterocyclic Hybrids Bearing Sulfonamide Moiety.
Castaño LF; Quiroga J; Abonia R; Insuasty D; Vidal OM; Seña R; Rubio V; Puerto G; Nogueras M; Cobo J; Guzman J; Insuasty A; Insuasty B
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293443
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Biological Activity and Molecular Docking Studies of Heterocyclic Chalcones.
Kamra N; Rani S; Thakral S; Singh A; Sangwan PL; Singh SK; Thakral S; Singh V; Kumar D
Chem Biodivers; 2022 Sep; 19(9):e202200560. PubMed ID: 35962990
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Evaluation of Novel Indole Hybrid Chalcones and Their Antiproliferative and Antioxidant Activity.
Kudličková Z; Michalková R; Salayová A; Ksiažek M; Vilková M; Bekešová S; Mojžiš J
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764359
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
Gibson MZ; Nguyen MA; Zingales SK
Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
[TBL] [Abstract][Full Text] [Related]
8. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Antioxidant Potency of New Naphthalene-Based Chalcone Derivatives: Design, Synthesis, Antioxidant Evaluation, Docking Study, DFT Calculations.
Balamon MG; El-Bordany EA; Mahmoud NFH; Hamed AA; Swilem AE
Chem Biodivers; 2023 Dec; 20(12):e202301344. PubMed ID: 37909089
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity of novel 3-(furan-2-yl)pyrazolyl and 3-(thiophen-2-yl)pyrazolyl hybrid chalcones: Synthesis and in vitro studies.
Helmy MT; Sroor FM; Mahrous KF; Mahmoud K; Hassaneen HM; Saleh FM; Abdelhamid IA; Mohamed Teleb MA
Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100381. PubMed ID: 34939695
[TBL] [Abstract][Full Text] [Related]
11. Imidazopyridine chalcones as potent anticancer agents: Synthesis, single-crystal X-ray, docking, DFT and SAR studies.
Soumyashree DK; Reddy DS; Nagarajaiah H; Naik L; Savanur HM; Shilpa CD; Sunitha Kumari M; Shanavaz H; Padmashali B
Arch Pharm (Weinheim); 2023 Jul; 356(7):e2300106. PubMed ID: 37208792
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial, Antioxidant, and Anticancer Activities of Some Novel Isoxazole Ring Containing Chalcone and Dihydropyrazole Derivatives.
Shaik A; Bhandare RR; Palleapati K; Nissankararao S; Kancharlapalli V; Shaik S
Molecules; 2020 Feb; 25(5):. PubMed ID: 32110945
[TBL] [Abstract][Full Text] [Related]
13. Novel Tetrahydro-[1,2,4]triazolo[3,4-
Darwish MIM; Moustafa AM; Youssef AM; Mansour M; Yousef AI; El Omri A; Shawki HH; Mohamed MF; Hassaneen HM; Abdelhamid IA; Oishi H
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110575
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Characterization and Biological Evaluation of Indole-Pyrazole Amalgamated α-Cyano Substituted Chalcones.
Bhale PS; Shringare SN; Khade AB; Chavan HV
Anticancer Agents Med Chem; 2021 Oct; 21(16):2216-2223. PubMed ID: 33563183
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and anti-cancer activity of new chalcone derivatives containing naphthalene and fluorine moieties.
Lim YH; Oo CW; Koh RY; Voon GL; Yew MY; Yam MF; Loh YC
Drug Dev Res; 2020 Dec; 81(8):994-1003. PubMed ID: 32720715
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
17. Antiplasmodial activity of ferrocenyl chalcones: investigations into the role of ferrocene.
Wu X; Tiekink ER; Kostetski I; Kocherginsky N; Tan AL; Khoo SB; Wilairat P; Go ML
Eur J Pharm Sci; 2006 Feb; 27(2-3):175-87. PubMed ID: 16269240
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis and Anticancer Evaluation of New 1-allyl-4-oxo-6-(3,4,5- trimethoxyphenyl)-1,4-dihydropyrimidine-5-carbonitrile Bearing Pyrazole Moieties.
Osman NA; El-Sayed NS; Abdel Fattah HA; Almalki AJ; Kammoun AK; Ibrahim TS; Alharbi AS; Al-Mahmoudy AM
Curr Org Synth; 2023; 20(8):897-909. PubMed ID: 36941818
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities.
Ahmed AHH; Mohamed MFA; Allam RM; Nafady A; Mohamed SK; Gouda AE; Beshr EAM
Bioorg Chem; 2022 Dec; 129():106171. PubMed ID: 36166898
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines.
Safwat GM; Hassanin KMA; Mohammed ET; Ahmed EK; Abdel Rheim MR; Ameen MA; Abdel-Aziz M; Gouda AM; Peluso I; Almeer R; Abdel-Daim MM; Abdel-Wahab A
Oxid Med Cell Longev; 2021; 2021():4759821. PubMed ID: 35003514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]